Relay Therapeutics, Inc. (RLAY)

8.86 +0.16 (+1.84%) USD  |  NASDAQ  |  Feb 23, 13:37
More

Relay Therapeutics EBITDA (% of Quarterly Revenues)

EBITDA (% of Quarterly Revenues) Chart

View EBITDA (% of Quarterly Revenues) for RLAY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (% of Quarterly Revenues) Range, Past 5 Years

View EBITDA (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (% of Quarterly Revenues) Benchmarks

View EBITDA (% of Quarterly Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Celcuity, Inc. --
Prelude Therapeutics, Inc. Upgrade
Immunome, Inc. Upgrade
ImmunityBio, Inc. Upgrade